nodes	percent_of_prediction	percent_of_DWPC	metapath
Emtricitabine—Lamivudine—NME2—ovarian cancer	0.0253	0.674	CrCbGaD
Emtricitabine—DCK—myometrium—ovarian cancer	0.0204	0.118	CbGeAlD
Emtricitabine—DCK—embryo—ovarian cancer	0.0196	0.113	CbGeAlD
Emtricitabine—DCK—uterine cervix—ovarian cancer	0.0158	0.0917	CbGeAlD
Emtricitabine—DCK—decidua—ovarian cancer	0.0151	0.0873	CbGeAlD
Emtricitabine—DCK—endometrium—ovarian cancer	0.0143	0.0829	CbGeAlD
Emtricitabine—DCK—gonad—ovarian cancer	0.0133	0.0769	CbGeAlD
Emtricitabine—DCK—uterus—ovarian cancer	0.0132	0.0764	CbGeAlD
Emtricitabine—DCK—female reproductive system—ovarian cancer	0.0119	0.0687	CbGeAlD
Emtricitabine—DCK—bone marrow—ovarian cancer	0.0112	0.0648	CbGeAlD
Emtricitabine—Floxuridine—TYMS—ovarian cancer	0.0108	0.288	CrCbGaD
Emtricitabine—DCK—female gonad—ovarian cancer	0.0108	0.0625	CbGeAlD
Emtricitabine—DCK—vagina—ovarian cancer	0.0107	0.0621	CbGeAlD
Emtricitabine—DCK—testis—ovarian cancer	0.00958	0.0554	CbGeAlD
Emtricitabine—DCK—Doxorubicin—Epirubicin—ovarian cancer	0.00952	0.519	CbGdCrCtD
Emtricitabine—DCK—Epirubicin—Doxorubicin—ovarian cancer	0.00881	0.481	CbGdCrCtD
Emtricitabine—DCK—lymph node—ovarian cancer	0.00695	0.0402	CbGeAlD
Emtricitabine—Lamivudine—ABCB1—ovarian cancer	0.00141	0.0376	CrCbGaD
Emtricitabine—Neuropathy peripheral—Docetaxel—ovarian cancer	0.00127	0.00165	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00125	0.00163	CcSEcCtD
Emtricitabine—Fatigue—Vinorelbine—ovarian cancer	0.00125	0.00162	CcSEcCtD
Emtricitabine—Hypersensitivity—Topotecan—ovarian cancer	0.00125	0.00162	CcSEcCtD
Emtricitabine—Pain—Vinorelbine—ovarian cancer	0.00124	0.00161	CcSEcCtD
Emtricitabine—Immune system disorder—Paclitaxel—ovarian cancer	0.00124	0.00161	CcSEcCtD
Emtricitabine—Mediastinal disorder—Paclitaxel—ovarian cancer	0.00124	0.00161	CcSEcCtD
Emtricitabine—Renal failure acute—Epirubicin—ovarian cancer	0.00123	0.0016	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Docetaxel—ovarian cancer	0.00123	0.00159	CcSEcCtD
Emtricitabine—Hypersensitivity—Melphalan—ovarian cancer	0.00122	0.00159	CcSEcCtD
Emtricitabine—Asthenia—Topotecan—ovarian cancer	0.00122	0.00158	CcSEcCtD
Emtricitabine—Vomiting—Chlorambucil—ovarian cancer	0.00121	0.00157	CcSEcCtD
Emtricitabine—Mental disorder—Paclitaxel—ovarian cancer	0.0012	0.00156	CcSEcCtD
Emtricitabine—Pruritus—Topotecan—ovarian cancer	0.0012	0.00156	CcSEcCtD
Emtricitabine—Malnutrition—Paclitaxel—ovarian cancer	0.0012	0.00155	CcSEcCtD
Emtricitabine—Renal impairment—Epirubicin—ovarian cancer	0.00119	0.00155	CcSEcCtD
Emtricitabine—Asthenia—Melphalan—ovarian cancer	0.00119	0.00155	CcSEcCtD
Emtricitabine—Dermatitis bullous—Epirubicin—ovarian cancer	0.00119	0.00154	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00119	0.00154	CcSEcCtD
Emtricitabine—Pruritus—Melphalan—ovarian cancer	0.00118	0.00152	CcSEcCtD
Emtricitabine—Rhinitis—Docetaxel—ovarian cancer	0.00117	0.00151	CcSEcCtD
Emtricitabine—Hepatitis—Docetaxel—ovarian cancer	0.00117	0.00151	CcSEcCtD
Emtricitabine—Diarrhoea—Topotecan—ovarian cancer	0.00116	0.00151	CcSEcCtD
Emtricitabine—Back pain—Paclitaxel—ovarian cancer	0.00116	0.0015	CcSEcCtD
Emtricitabine—Pharyngitis—Docetaxel—ovarian cancer	0.00116	0.0015	CcSEcCtD
Emtricitabine—Urticaria—Vinorelbine—ovarian cancer	0.00115	0.0015	CcSEcCtD
Emtricitabine—Urinary tract disorder—Docetaxel—ovarian cancer	0.00115	0.00149	CcSEcCtD
Emtricitabine—Abdominal pain—Vinorelbine—ovarian cancer	0.00115	0.00149	CcSEcCtD
Emtricitabine—Body temperature increased—Vinorelbine—ovarian cancer	0.00115	0.00149	CcSEcCtD
Emtricitabine—Connective tissue disorder—Docetaxel—ovarian cancer	0.00115	0.00148	CcSEcCtD
Emtricitabine—Urethral disorder—Docetaxel—ovarian cancer	0.00114	0.00148	CcSEcCtD
Emtricitabine—Renal failure acute—Doxorubicin—ovarian cancer	0.00114	0.00148	CcSEcCtD
Emtricitabine—Diarrhoea—Melphalan—ovarian cancer	0.00114	0.00147	CcSEcCtD
Emtricitabine—Nausea—Chlorambucil—ovarian cancer	0.00113	0.00147	CcSEcCtD
Emtricitabine—Dizziness—Topotecan—ovarian cancer	0.00112	0.00146	CcSEcCtD
Emtricitabine—Anaemia—Paclitaxel—ovarian cancer	0.00111	0.00143	CcSEcCtD
Emtricitabine—Renal impairment—Doxorubicin—ovarian cancer	0.0011	0.00143	CcSEcCtD
Emtricitabine—Dermatitis bullous—Doxorubicin—ovarian cancer	0.0011	0.00143	CcSEcCtD
Emtricitabine—Angioedema—Paclitaxel—ovarian cancer	0.00109	0.00142	CcSEcCtD
Emtricitabine—Vomiting—Topotecan—ovarian cancer	0.00108	0.0014	CcSEcCtD
Emtricitabine—Rash—Topotecan—ovarian cancer	0.00107	0.00139	CcSEcCtD
Emtricitabine—Hypersensitivity—Vinorelbine—ovarian cancer	0.00107	0.00139	CcSEcCtD
Emtricitabine—Dermatitis—Topotecan—ovarian cancer	0.00107	0.00139	CcSEcCtD
Emtricitabine—Blood creatinine increased—Epirubicin—ovarian cancer	0.00106	0.00138	CcSEcCtD
Emtricitabine—Headache—Topotecan—ovarian cancer	0.00106	0.00138	CcSEcCtD
Emtricitabine—Vomiting—Melphalan—ovarian cancer	0.00106	0.00137	CcSEcCtD
Emtricitabine—Immune system disorder—Docetaxel—ovarian cancer	0.00105	0.00136	CcSEcCtD
Emtricitabine—Mediastinal disorder—Docetaxel—ovarian cancer	0.00105	0.00136	CcSEcCtD
Emtricitabine—Rash—Melphalan—ovarian cancer	0.00105	0.00136	CcSEcCtD
Emtricitabine—Dermatitis—Melphalan—ovarian cancer	0.00105	0.00136	CcSEcCtD
Emtricitabine—Cough—Paclitaxel—ovarian cancer	0.00104	0.00135	CcSEcCtD
Emtricitabine—Asthenia—Vinorelbine—ovarian cancer	0.00104	0.00135	CcSEcCtD
Emtricitabine—Hypokalaemia—Epirubicin—ovarian cancer	0.00103	0.00134	CcSEcCtD
Emtricitabine—Pruritus—Vinorelbine—ovarian cancer	0.00103	0.00133	CcSEcCtD
Emtricitabine—Breast disorder—Epirubicin—ovarian cancer	0.00103	0.00133	CcSEcCtD
Emtricitabine—Mental disorder—Docetaxel—ovarian cancer	0.00102	0.00132	CcSEcCtD
Emtricitabine—Myalgia—Paclitaxel—ovarian cancer	0.00102	0.00132	CcSEcCtD
Emtricitabine—Arthralgia—Paclitaxel—ovarian cancer	0.00102	0.00132	CcSEcCtD
Emtricitabine—Nasopharyngitis—Epirubicin—ovarian cancer	0.00102	0.00132	CcSEcCtD
Emtricitabine—Anxiety—Paclitaxel—ovarian cancer	0.00102	0.00132	CcSEcCtD
Emtricitabine—Malnutrition—Docetaxel—ovarian cancer	0.00101	0.00132	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00101	0.00131	CcSEcCtD
Emtricitabine—Nausea—Topotecan—ovarian cancer	0.00101	0.00131	CcSEcCtD
Emtricitabine—Muscular weakness—Epirubicin—ovarian cancer	0.001	0.0013	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.001	0.0013	CcSEcCtD
Emtricitabine—Diarrhoea—Vinorelbine—ovarian cancer	0.000994	0.00129	CcSEcCtD
Emtricitabine—Nausea—Melphalan—ovarian cancer	0.000987	0.00128	CcSEcCtD
Emtricitabine—Blood creatinine increased—Doxorubicin—ovarian cancer	0.000985	0.00128	CcSEcCtD
Emtricitabine—Back pain—Docetaxel—ovarian cancer	0.000981	0.00127	CcSEcCtD
Emtricitabine—Infection—Paclitaxel—ovarian cancer	0.00097	0.00126	CcSEcCtD
Emtricitabine—Pancreatitis—Epirubicin—ovarian cancer	0.000963	0.00125	CcSEcCtD
Emtricitabine—Dizziness—Vinorelbine—ovarian cancer	0.00096	0.00125	CcSEcCtD
Emtricitabine—Nervous system disorder—Paclitaxel—ovarian cancer	0.000958	0.00124	CcSEcCtD
Emtricitabine—Hypokalaemia—Doxorubicin—ovarian cancer	0.000957	0.00124	CcSEcCtD
Emtricitabine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000956	0.00124	CcSEcCtD
Emtricitabine—Breast disorder—Doxorubicin—ovarian cancer	0.00095	0.00123	CcSEcCtD
Emtricitabine—Skin disorder—Paclitaxel—ovarian cancer	0.000949	0.00123	CcSEcCtD
Emtricitabine—Nasopharyngitis—Doxorubicin—ovarian cancer	0.00094	0.00122	CcSEcCtD
Emtricitabine—Anaemia—Docetaxel—ovarian cancer	0.000938	0.00122	CcSEcCtD
Emtricitabine—Muscular weakness—Doxorubicin—ovarian cancer	0.000927	0.0012	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000927	0.0012	CcSEcCtD
Emtricitabine—Vomiting—Vinorelbine—ovarian cancer	0.000923	0.0012	CcSEcCtD
Emtricitabine—Neutropenia—Epirubicin—ovarian cancer	0.000918	0.00119	CcSEcCtD
Emtricitabine—Rash—Vinorelbine—ovarian cancer	0.000916	0.00119	CcSEcCtD
Emtricitabine—Dermatitis—Vinorelbine—ovarian cancer	0.000915	0.00119	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000913	0.00118	CcSEcCtD
Emtricitabine—Headache—Vinorelbine—ovarian cancer	0.00091	0.00118	CcSEcCtD
Emtricitabine—Pancreatitis—Doxorubicin—ovarian cancer	0.000891	0.00116	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00089	0.00115	CcSEcCtD
Emtricitabine—Weight decreased—Epirubicin—ovarian cancer	0.000889	0.00115	CcSEcCtD
Emtricitabine—Hyperglycaemia—Epirubicin—ovarian cancer	0.000886	0.00115	CcSEcCtD
Emtricitabine—Cough—Docetaxel—ovarian cancer	0.000885	0.00115	CcSEcCtD
Emtricitabine—Insomnia—Paclitaxel—ovarian cancer	0.000884	0.00115	CcSEcCtD
Emtricitabine—Pneumonia—Epirubicin—ovarian cancer	0.000881	0.00114	CcSEcCtD
Emtricitabine—Paraesthesia—Paclitaxel—ovarian cancer	0.000877	0.00114	CcSEcCtD
Emtricitabine—Infestation NOS—Epirubicin—ovarian cancer	0.000876	0.00114	CcSEcCtD
Emtricitabine—Infestation—Epirubicin—ovarian cancer	0.000876	0.00114	CcSEcCtD
Emtricitabine—Dyspnoea—Paclitaxel—ovarian cancer	0.000871	0.00113	CcSEcCtD
Emtricitabine—Myalgia—Docetaxel—ovarian cancer	0.000864	0.00112	CcSEcCtD
Emtricitabine—Arthralgia—Docetaxel—ovarian cancer	0.000864	0.00112	CcSEcCtD
Emtricitabine—Nausea—Vinorelbine—ovarian cancer	0.000863	0.00112	CcSEcCtD
Emtricitabine—Renal failure—Epirubicin—ovarian cancer	0.000861	0.00112	CcSEcCtD
Emtricitabine—Dyspepsia—Paclitaxel—ovarian cancer	0.00086	0.00111	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000858	0.00111	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000858	0.00111	CcSEcCtD
Emtricitabine—Urinary tract infection—Epirubicin—ovarian cancer	0.000851	0.0011	CcSEcCtD
Emtricitabine—Neutropenia—Doxorubicin—ovarian cancer	0.00085	0.0011	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000845	0.00109	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000843	0.00109	CcSEcCtD
Emtricitabine—Fatigue—Paclitaxel—ovarian cancer	0.000842	0.00109	CcSEcCtD
Emtricitabine—Pain—Paclitaxel—ovarian cancer	0.000835	0.00108	CcSEcCtD
Emtricitabine—Haematuria—Epirubicin—ovarian cancer	0.000835	0.00108	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000828	0.00107	CcSEcCtD
Emtricitabine—Infection—Docetaxel—ovarian cancer	0.000823	0.00107	CcSEcCtD
Emtricitabine—Weight decreased—Doxorubicin—ovarian cancer	0.000822	0.00107	CcSEcCtD
Emtricitabine—Sinusitis—Epirubicin—ovarian cancer	0.000822	0.00107	CcSEcCtD
Emtricitabine—Hyperglycaemia—Doxorubicin—ovarian cancer	0.00082	0.00106	CcSEcCtD
Emtricitabine—Pneumonia—Doxorubicin—ovarian cancer	0.000815	0.00106	CcSEcCtD
Emtricitabine—Nervous system disorder—Docetaxel—ovarian cancer	0.000812	0.00105	CcSEcCtD
Emtricitabine—Thrombocytopenia—Docetaxel—ovarian cancer	0.000811	0.00105	CcSEcCtD
Emtricitabine—Infestation—Doxorubicin—ovarian cancer	0.00081	0.00105	CcSEcCtD
Emtricitabine—Infestation NOS—Doxorubicin—ovarian cancer	0.00081	0.00105	CcSEcCtD
Emtricitabine—Skin disorder—Docetaxel—ovarian cancer	0.000804	0.00104	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000799	0.00104	CcSEcCtD
Emtricitabine—Renal failure—Doxorubicin—ovarian cancer	0.000796	0.00103	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000794	0.00103	CcSEcCtD
Emtricitabine—Rhinitis—Epirubicin—ovarian cancer	0.000788	0.00102	CcSEcCtD
Emtricitabine—Urinary tract infection—Doxorubicin—ovarian cancer	0.000788	0.00102	CcSEcCtD
Emtricitabine—Hepatitis—Epirubicin—ovarian cancer	0.000786	0.00102	CcSEcCtD
Emtricitabine—Pharyngitis—Epirubicin—ovarian cancer	0.00078	0.00101	CcSEcCtD
Emtricitabine—Urinary tract disorder—Epirubicin—ovarian cancer	0.000776	0.00101	CcSEcCtD
Emtricitabine—Urticaria—Paclitaxel—ovarian cancer	0.000776	0.00101	CcSEcCtD
Emtricitabine—Haematuria—Doxorubicin—ovarian cancer	0.000773	0.001	CcSEcCtD
Emtricitabine—Connective tissue disorder—Epirubicin—ovarian cancer	0.000772	0.001	CcSEcCtD
Emtricitabine—Abdominal pain—Paclitaxel—ovarian cancer	0.000772	0.001	CcSEcCtD
Emtricitabine—Body temperature increased—Paclitaxel—ovarian cancer	0.000772	0.001	CcSEcCtD
Emtricitabine—Urethral disorder—Epirubicin—ovarian cancer	0.000771	0.000999	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000766	0.000993	CcSEcCtD
Emtricitabine—Sinusitis—Doxorubicin—ovarian cancer	0.00076	0.000986	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000754	0.000978	CcSEcCtD
Emtricitabine—Insomnia—Docetaxel—ovarian cancer	0.000749	0.000971	CcSEcCtD
Emtricitabine—Paraesthesia—Docetaxel—ovarian cancer	0.000744	0.000964	CcSEcCtD
Emtricitabine—Dyspnoea—Docetaxel—ovarian cancer	0.000738	0.000957	CcSEcCtD
Emtricitabine—Rhinitis—Doxorubicin—ovarian cancer	0.000729	0.000945	CcSEcCtD
Emtricitabine—Dyspepsia—Docetaxel—ovarian cancer	0.000729	0.000945	CcSEcCtD
Emtricitabine—Hepatitis—Doxorubicin—ovarian cancer	0.000727	0.000943	CcSEcCtD
Emtricitabine—Pharyngitis—Doxorubicin—ovarian cancer	0.000722	0.000936	CcSEcCtD
Emtricitabine—Hypersensitivity—Paclitaxel—ovarian cancer	0.00072	0.000933	CcSEcCtD
Emtricitabine—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000718	0.000931	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000715	0.000927	CcSEcCtD
Emtricitabine—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000715	0.000927	CcSEcCtD
Emtricitabine—Fatigue—Docetaxel—ovarian cancer	0.000714	0.000926	CcSEcCtD
Emtricitabine—Urethral disorder—Doxorubicin—ovarian cancer	0.000713	0.000924	CcSEcCtD
Emtricitabine—Immune system disorder—Epirubicin—ovarian cancer	0.00071	0.000921	CcSEcCtD
Emtricitabine—Mediastinal disorder—Epirubicin—ovarian cancer	0.000708	0.000919	CcSEcCtD
Emtricitabine—Pain—Docetaxel—ovarian cancer	0.000708	0.000918	CcSEcCtD
Emtricitabine—Asthenia—Paclitaxel—ovarian cancer	0.000701	0.000909	CcSEcCtD
Emtricitabine—Pruritus—Paclitaxel—ovarian cancer	0.000691	0.000896	CcSEcCtD
Emtricitabine—Mental disorder—Epirubicin—ovarian cancer	0.000689	0.000893	CcSEcCtD
Emtricitabine—Malnutrition—Epirubicin—ovarian cancer	0.000684	0.000887	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000677	0.000878	CcSEcCtD
Emtricitabine—Diarrhoea—Paclitaxel—ovarian cancer	0.000668	0.000867	CcSEcCtD
Emtricitabine—Back pain—Epirubicin—ovarian cancer	0.000662	0.000858	CcSEcCtD
Emtricitabine—Immune system disorder—Doxorubicin—ovarian cancer	0.000657	0.000852	CcSEcCtD
Emtricitabine—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000656	0.00085	CcSEcCtD
Emtricitabine—Abdominal pain—Docetaxel—ovarian cancer	0.000655	0.000849	CcSEcCtD
Emtricitabine—Body temperature increased—Docetaxel—ovarian cancer	0.000655	0.000849	CcSEcCtD
Emtricitabine—Dizziness—Paclitaxel—ovarian cancer	0.000646	0.000838	CcSEcCtD
Emtricitabine—Mental disorder—Doxorubicin—ovarian cancer	0.000637	0.000826	CcSEcCtD
Emtricitabine—Malnutrition—Doxorubicin—ovarian cancer	0.000633	0.000821	CcSEcCtD
Emtricitabine—Anaemia—Epirubicin—ovarian cancer	0.000632	0.00082	CcSEcCtD
Emtricitabine—Vomiting—Paclitaxel—ovarian cancer	0.000621	0.000805	CcSEcCtD
Emtricitabine—Rash—Paclitaxel—ovarian cancer	0.000616	0.000799	CcSEcCtD
Emtricitabine—Dermatitis—Paclitaxel—ovarian cancer	0.000615	0.000798	CcSEcCtD
Emtricitabine—Back pain—Doxorubicin—ovarian cancer	0.000612	0.000794	CcSEcCtD
Emtricitabine—Headache—Paclitaxel—ovarian cancer	0.000612	0.000793	CcSEcCtD
Emtricitabine—Hypersensitivity—Docetaxel—ovarian cancer	0.00061	0.000791	CcSEcCtD
Emtricitabine—Cough—Epirubicin—ovarian cancer	0.000597	0.000774	CcSEcCtD
Emtricitabine—Asthenia—Docetaxel—ovarian cancer	0.000594	0.00077	CcSEcCtD
Emtricitabine—Pruritus—Docetaxel—ovarian cancer	0.000586	0.000759	CcSEcCtD
Emtricitabine—Anaemia—Doxorubicin—ovarian cancer	0.000585	0.000759	CcSEcCtD
Emtricitabine—Myalgia—Epirubicin—ovarian cancer	0.000583	0.000755	CcSEcCtD
Emtricitabine—Arthralgia—Epirubicin—ovarian cancer	0.000583	0.000755	CcSEcCtD
Emtricitabine—Anxiety—Epirubicin—ovarian cancer	0.000581	0.000753	CcSEcCtD
Emtricitabine—Nausea—Paclitaxel—ovarian cancer	0.00058	0.000752	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000579	0.00075	CcSEcCtD
Emtricitabine—Diarrhoea—Docetaxel—ovarian cancer	0.000567	0.000734	CcSEcCtD
Emtricitabine—Infection—Epirubicin—ovarian cancer	0.000555	0.000719	CcSEcCtD
Emtricitabine—Cough—Doxorubicin—ovarian cancer	0.000553	0.000716	CcSEcCtD
Emtricitabine—Nervous system disorder—Epirubicin—ovarian cancer	0.000548	0.00071	CcSEcCtD
Emtricitabine—Dizziness—Docetaxel—ovarian cancer	0.000548	0.00071	CcSEcCtD
Emtricitabine—Thrombocytopenia—Epirubicin—ovarian cancer	0.000547	0.000709	CcSEcCtD
Emtricitabine—Skin disorder—Epirubicin—ovarian cancer	0.000542	0.000703	CcSEcCtD
Emtricitabine—Myalgia—Doxorubicin—ovarian cancer	0.000539	0.000699	CcSEcCtD
Emtricitabine—Arthralgia—Doxorubicin—ovarian cancer	0.000539	0.000699	CcSEcCtD
Emtricitabine—Anxiety—Doxorubicin—ovarian cancer	0.000537	0.000696	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000535	0.000694	CcSEcCtD
Emtricitabine—Vomiting—Docetaxel—ovarian cancer	0.000526	0.000683	CcSEcCtD
Emtricitabine—Rash—Docetaxel—ovarian cancer	0.000522	0.000677	CcSEcCtD
Emtricitabine—Dermatitis—Docetaxel—ovarian cancer	0.000522	0.000676	CcSEcCtD
Emtricitabine—Headache—Docetaxel—ovarian cancer	0.000519	0.000673	CcSEcCtD
Emtricitabine—Infection—Doxorubicin—ovarian cancer	0.000513	0.000666	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000509	0.00066	CcSEcCtD
Emtricitabine—Nervous system disorder—Doxorubicin—ovarian cancer	0.000507	0.000657	CcSEcCtD
Emtricitabine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000506	0.000656	CcSEcCtD
Emtricitabine—Insomnia—Epirubicin—ovarian cancer	0.000505	0.000655	CcSEcCtD
Emtricitabine—Skin disorder—Doxorubicin—ovarian cancer	0.000502	0.000651	CcSEcCtD
Emtricitabine—Paraesthesia—Epirubicin—ovarian cancer	0.000501	0.00065	CcSEcCtD
Emtricitabine—Dyspnoea—Epirubicin—ovarian cancer	0.000498	0.000646	CcSEcCtD
Emtricitabine—Nausea—Docetaxel—ovarian cancer	0.000492	0.000638	CcSEcCtD
Emtricitabine—Dyspepsia—Epirubicin—ovarian cancer	0.000492	0.000637	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000482	0.000625	CcSEcCtD
Emtricitabine—Fatigue—Epirubicin—ovarian cancer	0.000482	0.000624	CcSEcCtD
Emtricitabine—Pain—Epirubicin—ovarian cancer	0.000478	0.000619	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000471	0.00061	CcSEcCtD
Emtricitabine—Insomnia—Doxorubicin—ovarian cancer	0.000467	0.000606	CcSEcCtD
Emtricitabine—Paraesthesia—Doxorubicin—ovarian cancer	0.000464	0.000602	CcSEcCtD
Emtricitabine—Dyspnoea—Doxorubicin—ovarian cancer	0.000461	0.000597	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000457	0.000592	CcSEcCtD
Emtricitabine—Dyspepsia—Doxorubicin—ovarian cancer	0.000455	0.00059	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000446	0.000578	CcSEcCtD
Emtricitabine—Fatigue—Doxorubicin—ovarian cancer	0.000446	0.000578	CcSEcCtD
Emtricitabine—Urticaria—Epirubicin—ovarian cancer	0.000444	0.000575	CcSEcCtD
Emtricitabine—Pain—Doxorubicin—ovarian cancer	0.000442	0.000573	CcSEcCtD
Emtricitabine—Abdominal pain—Epirubicin—ovarian cancer	0.000441	0.000572	CcSEcCtD
Emtricitabine—Body temperature increased—Epirubicin—ovarian cancer	0.000441	0.000572	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000423	0.000548	CcSEcCtD
Emtricitabine—Hypersensitivity—Epirubicin—ovarian cancer	0.000411	0.000533	CcSEcCtD
Emtricitabine—Urticaria—Doxorubicin—ovarian cancer	0.000411	0.000532	CcSEcCtD
Emtricitabine—Body temperature increased—Doxorubicin—ovarian cancer	0.000409	0.00053	CcSEcCtD
Emtricitabine—Abdominal pain—Doxorubicin—ovarian cancer	0.000409	0.00053	CcSEcCtD
Emtricitabine—Asthenia—Epirubicin—ovarian cancer	0.000401	0.00052	CcSEcCtD
Emtricitabine—Pruritus—Epirubicin—ovarian cancer	0.000395	0.000512	CcSEcCtD
Emtricitabine—Diarrhoea—Epirubicin—ovarian cancer	0.000382	0.000495	CcSEcCtD
Emtricitabine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000381	0.000494	CcSEcCtD
Emtricitabine—Asthenia—Doxorubicin—ovarian cancer	0.000371	0.000481	CcSEcCtD
Emtricitabine—Dizziness—Epirubicin—ovarian cancer	0.000369	0.000479	CcSEcCtD
Emtricitabine—Pruritus—Doxorubicin—ovarian cancer	0.000366	0.000474	CcSEcCtD
Emtricitabine—Vomiting—Epirubicin—ovarian cancer	0.000355	0.00046	CcSEcCtD
Emtricitabine—Diarrhoea—Doxorubicin—ovarian cancer	0.000354	0.000458	CcSEcCtD
Emtricitabine—Rash—Epirubicin—ovarian cancer	0.000352	0.000457	CcSEcCtD
Emtricitabine—Dermatitis—Epirubicin—ovarian cancer	0.000352	0.000456	CcSEcCtD
Emtricitabine—Headache—Epirubicin—ovarian cancer	0.00035	0.000454	CcSEcCtD
Emtricitabine—Dizziness—Doxorubicin—ovarian cancer	0.000342	0.000443	CcSEcCtD
Emtricitabine—Nausea—Epirubicin—ovarian cancer	0.000332	0.00043	CcSEcCtD
Emtricitabine—Vomiting—Doxorubicin—ovarian cancer	0.000329	0.000426	CcSEcCtD
Emtricitabine—Rash—Doxorubicin—ovarian cancer	0.000326	0.000422	CcSEcCtD
Emtricitabine—Dermatitis—Doxorubicin—ovarian cancer	0.000326	0.000422	CcSEcCtD
Emtricitabine—Headache—Doxorubicin—ovarian cancer	0.000324	0.00042	CcSEcCtD
Emtricitabine—Nausea—Doxorubicin—ovarian cancer	0.000307	0.000398	CcSEcCtD
